Abstract:Brain stereotactic injection of LPC leads to local robust demyelination and reactive astrogliosis in the corpus callosum of mice. Supplementary TGF‐β1 binds to its receptor TGF‐βRI/II and then promotes the translocation of downstream molecule Smad3 into the nuclei. As a transcription factor, activated Smad3 regulates the expression of corresponding genes (such as MAG and MBP) to exert subsequent functions. Specifically, activation of TGF‐β1 pathway accelerates the maturation and migration processes of OLs, and restores the reactive astrogliosis probably through regulating the p38 MAPK signal pathway. Ultimately, supplement of TGF‐β1 significantly attenuates the demyelinating lesion and behavioral disorders in LPC modeling mice. In central nervous system (CNS), demyelination is a pathological process featured with a loss of myelin sheaths around axons, which is responsible for the diseases of multiple sclerosis, neuromyelitis optica, and so on. Transforming growth factor‐beta1 (TGF‐β1) is a multifunctional cytokine participating in abundant physiological and pathological processes in CNS. However, the effects of TGF‐β1 on CNS demyelinating disease and its underlying mechanisms are controversial and not well understood. Herein, we evaluated the protective potential of TGF‐β1 in a rodent demyelinating model established by lysophosphatidylcholine (LPC) injection. It was identified that supplement of TGF‐β1 evidently rescued the cognitive deficit and motor dysfunction in LPC modeling mice assessed by novel object recognition and balance beam behavioral tests. Besides, quantified by luxol fast blue staining, immunofluorescence, and western blot, administration of TGF‐β1 was found to significantly ameliorate the demyelinating lesion and reactive astrogliosis by suppressing p38 MAPK pathway. Mechanistically, the results of in vitro experiments indicated that treatment of TGF‐β1 could directly promote the differentiation and migration of cultured oligodendrocytes. Our study revealed that modulating TGF‐β1 activity might serve as a promising and innovative therapeutic strategy in CNS demyelinating diseases.

TGF-β1 protection against Aβ1-42-induced neuroinflammation and neurodegeneration in rats

Progress of the Action of TGF-β in Alzheimer's Disease

Effect of Brain-Derived Neurotrophic Factor on Tyrosine Kinase B and Endogenous Brain-Derived Neurotrophic Factor Expressions by Lateral Ventricle Infusion into AD Mice

Transforming growth factor‐β1 protects against white matter injury and reactive astrogliosis via the p38 MAPK pathway in rodent demyelinating model

Tβ4 and PDTC displayed recovery on the glial and neuronal alterations in an early Alzheimer’s disease model

TGF-β1 inhibits the neuronal apoptosis in rat hippocampus after traumatic brain injury

The role of transforming growth factor β1 /Smad pathway in Alzheimer's disease inflammation pathology

TGFβ1 Alleviates Axonal Injury by Regulating Microglia/macrophages Alternative Activation in Traumatic Brain Injury

The role of transforming growth factor β1 /Smad pathway in Alzheimer’s disease inflammation pathology

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Tetrahydroxy stilbene glycoside regulates TGF-β/fractalkine/CX3CR1 based on network pharmacology in APP/PS1 mouse model

Activation of the IL-17/TRAF6/NF-κB Pathway is Implicated in Aβ-induced Neurotoxicity

γ-Glutamylcysteine attenuates amyloid-β oligomers-induced neuroinflammation in microglia via blocking NF-κB signaling pathway

Tetramethylpyrazine Derivative T-006 Ameliorates the Amyloid-β Plagues of Transgenic Alzhermer's Mice by Modulation of TLR4-mediated MyD88/NF-κB Signaling

Tβ4 Ameliorates Oxidative Damage and Apoptosis Through ERK/MAPK and 5-HT1A Signaling Pathway in Aβ Insulted SH-SY5Y Cells.

Tat-haFGF 14–154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice Through the PI3K-CREB-IRE1α/XBP1 Pathway

Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway

A New Neuroprotective Candidate TJ1 Targeting Amyloidogenesis in 5xfad Alzheimer’s Disease Mice

Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats.

The relationship between TGF-β1 and cognitive function in the brain

CTBP1 Confers Protection for Hippocampal and Cortical Neurons in Rat Models of Alzheimer’s Disease